The impact of psychostimulant use on office based buprenorphine treatment retention
Abstract Background Over a million people have died from overdose since 1999, over 600,000. of which involved opioids. Treatment options that focus on overdose prevention are desperately needed and buprenorphine treatment is a form of opioid prevention if provided in a harm reduction setting. Co-mor...
Saved in:
| Main Authors: | Ryan Edgerton, Peter Rebeiro, Sam MacMaster, Lisa Bell, Parul Patel, Loren Ginn, Kyra Beach, Veeraj Shah, R. Lyle Cooper |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Harm Reduction Journal |
| Online Access: | https://doi.org/10.1186/s12954-025-01201-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological changes in the heart under the use of psychostimulants
by: S. V. Kozlov, et al.
Published: (2019-01-01) -
A Comparative Study of Office-Based Injectable Buprenorphine in Opioid-Dependence
by: R.M.M. Alhawi
Published: (2024-12-01) -
Use of psychostimulants in the management of treatment-resistant major depressive disorder
by: Sara L. Pucci, PharmD, BCPP
Published: (2025-08-01) -
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder
by: Marlene C. Lira, et al.
Published: (2025-02-01) -
Conditional Deletion of Translin/Trax in Dopaminergic Neurons Reveals No Impact on Psychostimulant Behaviors or Adiposity
by: Yunlong Liu, et al.
Published: (2025-07-01)